NUVAXOVID Trademark

Trademark Overview

On Tuesday, July 6, 2021, a trademark application was filed for NUVAXOVID with the United States Patent and Trademark Office. The USPTO has given the NUVAXOVID trademark a serial number of 90813423. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, May 2, 2024. This trademark is owned by Novavax, Inc.. The NUVAXOVID trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of Covid-19 vaccines, and clinical trials and post-market trials related to Covid-19 vaccines; consulting services in the field of research and development of Covid-19 vaccines; Covid-19 vaccine research and development
nuvaxovid

General Information

Serial Number90813423
Word MarkNUVAXOVID
Filing DateTuesday, July 6, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, May 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 8, 2022

Trademark Statements

Description of MarkThe mark consists of the word "NUVAXOVID" below a left and right-wing design joining at the center, made up of different shaped circles.
Goods and ServicesProviding medical and scientific research information in the field of Covid-19 vaccines, and clinical trials and post-market trials related to Covid-19 vaccines; consulting services in the field of research and development of Covid-19 vaccines; Covid-19 vaccine research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 15, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovavax, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameNovavax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Friday, July 9, 2021NEW APPLICATION ENTERED
Wednesday, September 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 16, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, February 1, 2022ASSIGNED TO EXAMINER
Wednesday, February 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 8, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 25, 2022SOU TEAS EXTENSION RECEIVED
Monday, July 25, 2022SOU EXTENSION 1 FILED
Monday, July 25, 2022SOU EXTENSION 1 GRANTED
Wednesday, July 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 13, 2023SOU EXTENSION 2 FILED
Thursday, April 13, 2023SOU EXTENSION 2 GRANTED
Saturday, April 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 1, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 1, 2023SOU EXTENSION 3 FILED
Wednesday, November 1, 2023SOU EXTENSION 3 GRANTED
Friday, November 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 2, 2024SOU EXTENSION 4 GRANTED
Thursday, May 2, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 2, 2024SOU EXTENSION 4 FILED
Friday, May 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

nuvaxovid covid vaccines research trials field development related vaccine consulting market